Luvixasertib (CFI-402257)
Product Specifications
CAS Number
1610759-22-2
Synonyms
Luvixasertib
SKU
C13298-5mg
Target
Serine/threonin kinase
Applications
Cell Cycle
Molecular Formula
C28H30N6O3
Additionnal Information
Luvixasertib (CFI-402257) is an inhibitor of threonine tyrosine kinase (TTK) with IC50 of 1.7 nM and Ki of 0.1 nM, respectively. It is a potential therapeutic for treating hepatocellular carcinoma that works directly by inhibiting cell-cycle checkpoints in cancer cells and indirectly by mobilizing immune cells from the tumor microenvironment.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUM1968-50 1x 50 µL
Thyroglobulin (Thyroidal Cell Marker) (TGB/1968R), 1mg/mL
Sign In for Pricing
View Details 
BNC040665-500 1x 500 µL
Smooth Muscle Actin (1A4), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-B682225-25MG 25 mg
4-Bromo-2-chlorobenzeneacetic Acid Ethyl Ester
Sign In for Pricing
View Details